NxStage Medical, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 9 rows in 2006. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2006-11-27: Reporting owner Brown Robert; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2006-05-30: Reporting owner Utterberg David S; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2006-05-30: Reporting owner PHILDIUS PETER P; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2006-05-30: Reporting owner REID PERPER; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2006-11-27 | Brown Robert Officer (Sr. Vice President, CFO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $8.92 exercise price | 2006-11-29 | |
| 2006-05-30 | Utterberg David S Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $10.83 exercise price | 2006-05-31 | |
| 2006-05-30 | PHILDIUS PETER P Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $10.83 exercise price | 2006-05-31 | |
| 2006-05-30 | REID PERPER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $10.83 exercise price | 2006-05-31 | |
| 2006-05-30 | MOORE CRAIG W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $10.83 exercise price | 2006-05-31 | |
| 2006-05-30 | Giannini Daniel A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $10.83 exercise price | 2006-05-31 | |
| 2006-05-30 | CHAMBON PHILIPPE Director, 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,000 14,000 owned after | $10.83 exercise price | 2006-05-31 | |
| 2006-03-24 | Licari Philip R Officer (SVP & Chief Operating Officer) | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −208,962 0 owned after | $4.10 exercise price | 2006-03-28 | |
| 2006-03-24 | Licari Philip R Officer (SVP & Chief Operating Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +208,962 208,962 owned after | $5.47 exercise price | 2006-03-28 |